HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1
- Resource Type
- Source
- Clinical Lymphoma Myeloma and Leukemia. 22:S350
- Subject
Cancer Research Oncology Hematology - Language
- ISSN
- 2152-2650